---
title: "Provision of EPR services"
ocid: "ocds-h6vhtk-07bc40"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07bc40"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-07bc40.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-07bc40.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "WARRINGTON AND HALTON TEACHING HOSPITALS NHS FOUNDATION TRUST"
published: "2026-11-16"
---

# Provision of EPR services

Buyer: WARRINGTON AND HALTON TEACHING HOSPITALS NHS FOUNDATION TRUST  
Current stage: Award  
OCID: ocds-h6vhtk-07bc40

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07bc40)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-07bc40.json)

## Summary

North Cheshire & Mersey NHS Foundation Trust is procuring continued provision, support and maintenance of its existing electronic patient record (EPR) environment: the Lorenzo and Ormis applications and their existing interfaces. The scope also adds the Lorenzo PatientAide module, with implementation, configuration, support and maintenance. These systems support patient administration, clinical documentation, diagnostics and theatre workflows, and exchange information with Trust and national systems. The work is intended to maintain safe continuity while the Trust prepares a replacement EPR. The buyer is North Cheshire & Mersey NHS Foundation Trust. Delivery is in Warrington, Cheshire, within the North West of England. This is specialist software supply and support, rather than a procurement of a new, full-scale replacement EPR; materially new modules or functionality beyond the stated continuity scope are excluded.

The procurement is complete and the Trust selected DH OpCo UK Ltd through a direct award. The award is pending, and the data records a future signature milestone. The Trust says technical dependencies in the incumbent environment leave no reasonable alternative supplier able to provide continuity and authorised support without disproportionate technical, operational and clinical risk. The award value is £4,411,737 excluding VAT (£5,294,084 including VAT). The contract period runs from 1 December 2026 to 30 November 2029. It covers one lot, with options and permitted adjustments for CPI indexation and evidenced third-party cost changes within the published maximum value. The Trust intends to procure its replacement EPR separately through competition; the direct award is limited to continuity and transition, not a longer-term commitment to the incumbent.

For suppliers that did not win, this award signals that the Trust’s existing EPR support is tightly bound to the incumbent software and its integrated environment. A credible competitor for the same continuity requirement would need demonstrable rights and authorised access to support Lorenzo and Ormis, product-specific technical knowledge, appropriate tooling, and the capability to maintain existing interfaces and service safely. Experience safeguarding clinical workflows, data integrity and information flows across clinical, diagnostic, theatre, Trust and national systems would be central, alongside the ability to support implementation and configuration of PatientAide. The Trust’s stated risks include interface failure, inaccurate or incomplete migration and disruption to care processes. The longer-term replacement EPR is intended to be a separate competitive procurement, so suppliers able to deliver a full replacement and transition should distinguish that capability from incumbent-only support.

## Notice

This transparency notice concerns the proposed direct award of a new agreement by North Cheshire & Mersey NHS Foundation Trust (the Trust) to DH OpCo UK Ltd for the continued provision, support and maintenance of the Trust's existing Electronic Patient Record (EPR) services, including the Lorenzo and Ormis applications and associated existing interfaces, together with Lorenzo PatientAide and its associated implementation, configuration, support and maintenance services. Lorenzo PatientAide is an additional module and was not included within the Trust's original agreement. The proposed agreement is intended to preserve the safe and continuous operation of clinically critical EPR services while the Trust undertakes a compliant re-procurement and, if required, implements and transitions to a replacement solution. The Trust may undertake that future procurement independently or in collaboration with another NHS organisation, depending on approved requirements and arrangements at that time. The Trust's existing arrangements contain options to extend the incumbent services beyond 23 November 2026 through up to two further 12-month periods, potentially providing continuity until November 2028. While these provisions provide short-term flexibility, no further contractual extension rights exist beyond November 2028. The proposed term reflects the Trust's current programme for procuring and implementing its future EPR arrangements, including the time required to complete the procurement, implementation, migration, integration, testing, training, clinical-safety assurance and transition activities. The Trust has considered the extension rights available under the existing arrangements, including the potential for continuity until November 2028. However, those rights do not provide a reasonable alternative to the proposed contract. They expire before the Trust's revised EPR programme allows sufficient time to complete the planned EPR mini-competition and associated approval processes, and then safely implement the replacement solution, including configuration, data migration, integration, testing, training, clinical-safety assurance and deployment. The additional period to 30 November 2029 is therefore required to maintain continuity while those activities are completed. Without it, the existing arrangements could end before the replacement EPR is operational, creating unacceptable clinical, operational and business-continuity risks. The proposed term is a time-limited continuity measure to support transition to a replacement EPR and is not a longer-term commitment to the incumbent solution. The Trust does not consider competition to be permanently absent: the proposed direct award does not extend to the future replacement EPR, which is intended to be procured separately through competition.

### Procurement Information

The Trust considers that the conditions in paragraph 6 of Schedule 5 to the Procurement Act 2023 are met. Due to an absence of competition for technical reasons, only DH OpCo UK Ltd can supply the services required under the proposed contract, and there are no reasonable alternatives to those services. For the continued Lorenzo and Ormis requirement, the Trust's assessment is that, because of the technical characteristics and dependencies of the incumbent EPR environment and the absence of a reasonable alternative capable of meeting the requirement without disproportionate technical, operational and clinical impact, only DH OpCo UK Ltd can provide the required continuity, authorised support and maintenance services. The Lorenzo and Ormis environment is integrated with the Trust's wider digital estate through established clinical, operational, diagnostic, internal, external and national NHS interfaces. The incumbent applications contain supplier-controlled and product-specific elements, including configurations, data structures, workflows, interfaces and supported upgrade pathways. Changing supplier for the incumbent environment would create disproportionate technical difficulties and material risk, including interface failure, incomplete or inaccurate data migration, disruption to clinical workflows and loss of continuity in clinically critical services. The proposed agreement also includes Lorenzo PatientAide, which was not included within the Trust's original contractual arrangements. Overall the Trust has considered whether the requirement could reasonably be met through alternative suppliers or a narrower solution including: Immediate competitive procurement and full EPR replacement before incumbent continuity is required. This would not provide a safely implemented replacement in time and would require procurement, configuration, migration, integration, testing, training, clinical-safety assurance and deployment. Appointment of a third party to support Lorenzo and Ormis. This is not reasonable unless that supplier can demonstrate lawful rights, authorised access, product-support capability, tooling, technical knowledge and the ability to assume responsibility for the integrated environment. No such reasonable alternative has been identified. Procuring an alternative solution during the proposed continuity period would require additional integration, configuration, interoperability, data-flow, testing, clinical-safety assurance and implementation activity. This would introduce additional technical and operational dependencies and a risk of duplication and disruption during the period in which the Trust is maintaining the existing EPR environment pending procurement and transition to its future solution. On the basis of its technical assessment, the Trust has concluded that separate procurement of this functionality would not provide a reasonable alternative without disproportionate technical and operational impact. Separate procurement of theatre functionality instead of Ormis. This would introduce an additional implementation and migration programme, require redevelopment and assurance of interfaces and could duplicate cost and transition activity. A shorter or narrower continuity arrangement. The proposed scope and duration are intended to provide continuity while the Trust undertakes its future EPR procurement, implementation and clinically safe transition. Use of an available framework or other competitive route. Competition remains intended for the future EPR solution but does not remove the present need for authorised incumbent support and safe continuity. The Trust has concluded, on the evidence available at the date of decision, that these alternatives do not reasonably meet the current requirement with an acceptable level of technical, operational and clinical risk. The EPR environment supports clinically critical and operational processes and exchanges information with other Trust and national systems. Failure or degradation could affect the availability, completeness or timely flow of information used in patient administration, clinical documentation, diagnostics, theatre workflows and other care processes. The direct award is based on the Trust's evidenced assessment of technical dependencies, lawful support position, interoperability requirements, transition activities and the risks associated with changing supplier before a safe replacement can be competitively procured and implemented. The maximum term to 30 November 2029 is intended to provide a controlled period to maintain the incumbent service, confirm the future operating model, conduct a compliant procurement, implement the selected solution and complete a clinically safe transition and exit. The Trust will keep the timetable under review.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/108275-2026 |
| Notice type | UK5 - Transparency Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Direct |
| Procurement method details | Direct award |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 16 Nov 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | 1 Dec 2026 - 30 Nov 2029 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | £4,411,737 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Pending |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | WARRINGTON AND HALTON TEACHING HOSPITALS NHS FOUNDATION TRUST |
| Locality | WARRINGTON |
| Postcode area | Warrington |
| Postcode | WA5 1QG |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD6 Cheshire |
| ITL 3 | TLD61 Warrington |
| Local authority | Warrington |
| Electoral ward | Bewsey and Whitecross |
| Westminster constituency | Warrington South |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | DH OPCO UK LTD |

## CPV Codes

### Divisions

- 72 - IT services: consulting, software development, Internet and support

### Codes

- 72268000 - Software supply services

## Release History

- 16 Nov 2026 at 09:07 - Award - UK5 - Transparency Notice - https://www.find-tender.service.gov.uk/Notice/108275-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/108275-2026
  16th November 2026 - Transparency notice on Find a Tender

## Notice URLs

- https://northcheshireandmersey.nhs.uk/
- https://www.dedalus.com/uki
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07bc40. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-07bc40.json.
